Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Basal Cell × Eflornithine × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Adenomatous Polyposis Coli 2 Urinary Bladder Neoplasms 1 Precancerous Conditions 1 Glioma 1 Colorectal Neoplasms 1 Colonic Polyps 1 Carcinoma, Basal Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Imiquimod 4 methyl 5-aminolevulinate 3 Photochemotherapy 2 Tretinoin 1 Surgical Procedures, Operative 1 Niacinamide 1 Fluorouracil 1 Electroporation 1 Eflornithine 1 Calcium Chloride 1 BF-200 ALA 1 Aminolevulinic Acid 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00005884 2019-12-13

Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

University of Wisconsin, Madison

Phase 3 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡